REACTIN: Regulatory activity inference of transcription factors underlying human diseases with application to breast cancer

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Zhu, Mingzhu ^a   Liu, Chun Chi ^b   Cheng, Chao ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

ChIP seq; Gene expression; Transcription factor

Indexed keywords

ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3;

ACCURACY; ALGORITHM; ARTICLE; BINDING AFFINITY; BREAST CANCER; CALCULATION; CANCER CELL; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; GENE EXPRESSION; GENE IDENTIFICATION; GENE INTERACTION; GENE TARGETING; HUMAN; HUMAN TISSUE; PREDICTION; PROBABILITY; PROTEIN BINDING; REGULATORY ACTIVITY INFERENCE; REGULATORY MECHANISM; SCORING SYSTEM; SURVIVAL TIME; TRANSCRIPTION REGULATION;

ALGORITHMS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; RECEPTORS, ESTROGEN; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS;

EID: 84880901715     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-504     Document Type: Article

References (68)

1. Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989, 245:371-378. 10.1126/science.2667136, 2667136.
2. Vaquerizas JM, Kummerfeld SK, Teichmann SA, Luscombe NM. A census of human transcription factors: function, expression and evolution. Nat Rev Genet 2009, 10:252-263. 10.1038/nrg2538, 19274049.
3. Babu MM, Luscombe NM, Aravind L, Gerstein M, Teichmann SA. Structure and evolution of transcriptional regulatory networks. Curr Opin Struct Biol 2004, 14:283-291. 10.1016/j.sbi.2004.05.004, 15193307.
4. Jones RG, Thompson CB. Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev 2009, 23:537-548. 10.1101/gad.1756509, 2763495, 19270154.
5. Westphal S, Kalthoff H. Apoptosis: targets in pancreatic cancer. Mol Cancer 2003, 2:6. 10.1186/1476-4598-2-6, 149420, 12605713.
6. Lemons D, McGinnis W. Genomic evolution of Hox gene clusters. Science 2006, 313:1918-1922. 10.1126/science.1132040, 17008523.
7. Elkon R, Linhart C, Sharan R, Shamir R, Shiloh Y. Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells. Genome Res 2003, 13:773-780. 10.1101/gr.947203, 430898, 12727897.
8. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676. 10.1016/j.cell.2006.07.024, 16904174.
9. Benayoun BA, Caburet S, Veitia RA. Forkhead transcription factors: key players in health and disease. Trends Genet 2011, 27:224-232. 10.1016/j.tig.2011.03.003, 21507500.
10. Introna M, Golay J. How can oncogenic transcription factors cause cancer: a critical review of the myb story. Leukemia 1999, 13:1301-1306. 10.1038/sj.leu.2401492, 10482978.
11. Darnell JE. Transcription factors as targets for cancer therapy. Nat Rev Cancer 2002, 2:740-749. 10.1038/nrc906, 12360277.
12. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991, 351:453-456. 10.1038/351453a0, 2046748.
13. Strano S, Dell'Orso S, Di Agostino S, Fontemaggi G, Sacchi A, Blandino G. Mutant p53: an oncogenic transcription factor. Oncogene 2007, 26:2212-2219. 10.1038/sj.onc.1210296, 17401430.
14. Barrett T, Troup DB, Wilhite SE, Ledoux P, Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, et al. NCBI GEO: archive for functional genomics data sets-10 years on. Nucleic Acids Res 2011, 39:D1005-D1010. 10.1093/nar/gkq1184, 3013736, 21097893.
15. Baggerly KA, Coombes KR, Hess KR, Stivers DN, Abruzzo LV, Zhang W. Identifying differentially expressed genes in cDNA microarray experiments. J Comput Biol 2001, 8:639-659. 10.1089/106652701753307539, 11747617.
16. Zhang H, Yu CY, Singer B, Xiong M. Recursive partitioning for tumor classification with gene expression microarray data. Proc Natl Acad Sci USA 2001, 98:6730-6735. 10.1073/pnas.111153698, 34421, 11381113.
17. Guo Z, Zhang T, Li X, Wang Q, Xu J, Yu H, Zhu J, Wang H, Wang C, Topol EJ, et al. Towards precise classification of cancers based on robust gene functional expression profiles. BMC Bioinformatics 2005, 6:58. 10.1186/1471-2105-6-58, 1274255, 15774002.
18. Rhodes DR, Kalyana-Sundaram S, Mahavisno V, Barrette TR, Ghosh D, Chinnaiyan AM. Mining for regulatory programs in the cancer transcriptome. Nat Genet 2005, 37:579-583. 10.1038/ng1578, 15920519.
19. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331. 10.1016/S0092-8674(00)81871-1, 9039259.
20. Sigal A, Rotter V. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. Cancer Res 2000, 60:6788-6793.
21. Rolley N, Butcher S, Milner J. Specific DNA binding by different classes of human p53 mutants. Oncogene 1995, 11:763-770.
22. Bullock AN, Henckel J, DeDecker BS, Johnson CM, Nikolova PV, Proctor MR, Lane DP, Fersht AR. Thermodynamic stability of wild-type and mutant p53 core domain. Proc Natl Acad Sci U S A 1997, 94:14338-14342. 10.1073/pnas.94.26.14338, 24967, 9405613.
23. Edlund K, Larsson O, Ameur A, Bunikis I, Gyllensten U, Leroy B, Sundstrom M, Micke P, Botling J, Soussi T. Data-driven unbiased curation of the TP53 tumor suppressor gene mutation database and validation by ultradeep sequencing of human tumors. Proc Natl Acad Sci USA 2012, 109:9551-9556. 10.1073/pnas.1200019109, 3386058, 22628563.
24. Cheng C, Li LM, Alves P, Gerstein M. Systematic identification of transcription factors associated with patient survival in cancers. BMC Genomics 2009, 10:225. 10.1186/1471-2164-10-225, 2686740, 19442316.
25. Cheng C, Yan X, Sun F, Li LM. Inferring activity changes of transcription factors by binding association with sorted expression profiles. BMC Bioinformatics 2007, 8:452. 10.1186/1471-2105-8-452, 2194743, 18021409.
26. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, et al. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 2007, 4:651-657. 10.1038/nmeth1068, 17558387.
27. Horak CE, Snyder M. ChIP-chip: a genomic approach for identifying transcription factor binding sites. Methods Enzymol 2002, 350:469-483.
28. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956. 10.1016/j.cell.2005.08.020, 3006442, 16153702.
29. Chen X, Xu H, Yuan P, Fang F, Huss M, Vega VB, Wong E, Orlov YL, Zhang W, Jiang J, et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 2008, 133:1106-1117. 10.1016/j.cell.2008.04.043, 18555785.
30. Kim J, Chu J, Shen X, Wang J, Orkin SH. An extended transcriptional network for pluripotency of embryonic stem cells. Cell 2008, 132:1049-1061. 10.1016/j.cell.2008.02.039, 18358816.
31. Cheng C, Min R, Gerstein M. TIP: a probabilistic method for identifying transcription factor target genes from ChIP-seq binding profiles. Bioinformatics 2011, 27:3221-3227. 10.1093/bioinformatics/btr552, 3223362, 22039215.
32. MacArthur S, Li XY, Li J, Brown JB, Chu HC, Zeng L, Grondona BP, Hechmer A, Simirenko L, Keranen SV, et al. Developmental roles of 21 Drosophila transcription factors are determined by quantitative differences in binding to an overlapping set of thousands of genomic regions. Genome Biol 2009, 10:R80. 10.1186/gb-2009-10-7-r80, 2728534, 19627575.
33. Kaplan T, Li XY, Sabo PJ, Thomas S, Stamatoyannopoulos JA, Biggin MD, Eisen MB. Quantitative models of the mechanisms that control genome-wide patterns of transcription factor binding during early Drosophila development. PLoS Genet 2011, 7:e1001290. 10.1371/journal.pgen.1001290, 3033374, 21304941.
34. ENCODE Project Consortium A user's guide to the encyclopedia of DNA elements (ENCODE). PLoS Bio 2011, 9:e1001046. ENCODE Project Consortium.
35. ENCODE Project Consortium Project The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004, 306:636--640. ENCODE Project Consortium.
36. Chen L, Wu G, Ji H. hmChIP: a database and web server for exploring publicly available human and mouse ChIP-seq and ChIP-chip data. Bioinformatics 2011, 27:1447-1448. 10.1093/bioinformatics/btr156, 3087956, 21450710.
37. Qin B, Zhou M, Ge Y, Taing L, Liu T, Wang Q, Wang S, Chen J, Shen L, Duan X, et al. CistromeMap: a knowledgebase and web server for ChIP-Seq and DNase-Seq studies in mouse and human. Bioinformatics 2012, 28:1411-1412. 10.1093/bioinformatics/bts157, 3348563, 22495751.
38. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
39. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, et al. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74. 10.1038/nature11247, 3439153, 22955616.
40. Hess KR, Anderson K, Symmans WF, Valero V, Ibrahim N, Mejia JA, Booser D, Theriault RL, Buzdar AU, Dempsey PJ, et al. Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol 2006, 24:4236-4244. 10.1200/JCO.2006.05.6861, 16896004.
41. Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, Pawitan Y, Hall P, Klaar S, Liu ET, Bergh J. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci USA 2005, 102:13550-13555. 10.1073/pnas.0506230102, 1197273, 16141321.
42. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524. 10.1038/nature03799, 1283098, 16049480.
43. Van'tVeer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. Nature 2002, 415:530-536. 10.1038/415530a, 11823860.
44. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
45. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL, Lapuk A, Neve RM, Qian Z, Ryder T, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006, 10:529-541. 10.1016/j.ccr.2006.10.009, 17157792.
46. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009. 10.1056/NEJMoa021967, 12490681.
47. Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006, 9:121-132. 10.1016/j.ccr.2006.01.013, 16473279.
48. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, et al. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006, 66:10292-10301. 10.1158/0008-5472.CAN-05-4414, 17079448.
49. C Comprehensive molecular portraits of human breast tumours. Nature 2012, 490:61-70. 10.1038/nature11412, 3465532, 23000897, C.
50. Hayashi SI, Eguchi H, Tanimoto K, Yoshida T, Omoto Y, Inoue A, Yoshida N, Yamaguchi Y. The expression and function of estrogen receptor alpha and beta in human breast cancer and its clinical application. Endocr Relat Cancer 2003, 10:193-202. 10.1677/erc.0.0100193, 12790782.
51. Ali S, Coombes RC. Estrogen receptor alpha in human breast cancer: occurrence and significance. J Mammary Gland Biol Neoplasia 2000, 5:271-281. 10.1023/A:1009594727358, 14973389.
52. Meyer KB, Carroll JS. FOXA1 and breast cancer risk. Nat Genet 2012, 44:1176-1177. 10.1038/ng.2449, 23104063.
53. Nakshatri H, Badve S. FOXA1 as a therapeutic target for breast cancer. Expert Opin Ther Targets 2007, 11:507-514. 10.1517/14728222.11.4.507, 17373880.
54. Giacinti L, Claudio PP, Lopez M, Giordano A. Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 2006, 11:1-8.
55. Huang Y, Ray S, Reed JC, Ibrado AM, Tang C, Nawabi A, Bhalla K. Estrogen increases intracellular p26Bcl-2 to p21Bax ratios and inhibits taxol-induced apoptosis of human breast cancer MCF-7 cells. Breast Cancer Res Treat 1997, 42:73-81. 10.1023/A:1005777219997, 9116321.
56. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43. 10.1016/j.cell.2005.05.008, 16009131.
57. Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, et al. Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours. Breast Cancer Res 2009, 11:R40. 10.1186/bcr2327, 2716509, 19549328.
58. Clevenger CV. Roles and regulation of stat family transcription factors in human breast cancer. Am J Pathol 2004, 165:1449-1460. 10.1016/S0002-9440(10)63403-7, 1618660, 15509516.
59. Chan SR, Vermi W, Luo J, Lucini L, Rickert C, Fowler AM, Lonardi S, Arthur C, Young LJ, Levy DE, et al. STAT1-deficient mice spontaneously develop estrogen receptor alpha-positive luminal mammary carcinomas. Breast Cancer Res 2012, 14:R16. 10.1186/bcr3100, 3496133, 22264274.
60. Kaplan DH, Shankaran V, Dighe AS, Stockert E, Aguet M, Old LJ, Schreiber RD. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 1998, 95:7556-7561. 10.1073/pnas.95.13.7556, 22681, 9636188.
61. Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc Natl Acad Sci USA 2000, 97:5208-5213. 10.1073/pnas.080469697, 25807, 10792030.
62. Townsend PA, Cragg MS, Davidson SM, McCormick J, Barry S, Lawrence KM, Knight RA, Hubank M, Chen PL, Latchman DS, Stephanou A. STAT-1 facilitates the ATM activated checkpoint pathway following DNA damage. J Cell Sci 2005, 118:1629-1639. 10.1242/jcs.01728, 15784679.
63. Wang S, Raven JF, Durbin JE, Koromilas AE. Stat1 phosphorylation determines Ras oncogenicity by regulating p27 kip1. PLoS One 2008, 3:e3476. 10.1371/journal.pone.0003476, 2568943, 18941537.
64. Johnson DG. The paradox of E2F1: oncogene and tumor suppressor gene. Mol Carcinog 2000, 27:151-157. 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C, 10708476.
65. Molina-Privado I, Jimenez PR, Montes-Moreno S, Chiodo Y, Rodriguez-Martinez M, Sanchez-Verde L, Iglesias T, Piris MA, Campanero MR. E2F4 plays a key role in Burkitt lymphoma tumorigenesis. Leukemia 2012, 26:2277-2285. 10.1038/leu.2012.99, 22475873.
66. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001, 98:5116-5121. 10.1073/pnas.091062498, 33173, 11309499.
67. Gerstein MB, Kundaje A, Hariharan M, Landt SG, Yan KK, Cheng C, Mu XJ, Khurana E, Rozowsky J, Alexander R, et al. Architecture of the human regulatory network derived from ENCODE data. Nature 2012, 489:91-100. 10.1038/nature11245, 22955619.
68. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264. 10.1093/biostatistics/4.2.249, 12925520.